Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 64 citing articles:

Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 554
Arginase 1 is a key driver of immune suppression in pancreatic cancer
Rosa E. Menjivar, Zeribe C. Nwosu, Wenting Du, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 78
RNAi-based drug design: considerations and future directions
Qi Tang, Anastasia Khvorova
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 341-364
Open Access | Times Cited: 73
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Necroptosis enhances ‘don’t eat me’ signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis
Cheng‐Yu Liao, Ge Li, Feng‐Ping Kang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment
Shiyu Liu, Fan Li, Qiongqiong Ma, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4016-4029
Open Access | Times Cited: 24
IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling
Chenlei Zheng, Junli Wang, Yu Zhou, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114088-114088
Open Access | Times Cited: 12
Barriers and opportunities in pancreatic cancer immunotherapy
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 11
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 22
Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer
Dipakkumar R. Prajapati, Caitlin Molczyk, Abhilasha Purohit, et al.
Cancer Letters (2023) Vol. 563, pp. 216185-216185
Closed Access | Times Cited: 17
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade
Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, et al.
Nature Cancer (2023) Vol. 4, Iss. 10, pp. 1455-1473
Open Access | Times Cited: 17
CXCR2 chemokine receptor – a master regulator in cancer and physiology
Gwendal Lazennec, Krishna Rajarathnam, Ann Richmond
Trends in Molecular Medicine (2023) Vol. 30, Iss. 1, pp. 37-55
Open Access | Times Cited: 17
LAG‐3 : recent developments in combinational therapies in cancer
Aude Chavanton, Flavie Mialhe, Jimena Abrey, et al.
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2494-2505
Open Access | Times Cited: 8
Recent progress of non-linear topological structure polymers: synthesis, and gene delivery
Chenfei Wang, Wei He, Feifei Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
Lin Feng, Shenyi Yin, Zijian Zhang, et al.
Cell (2024)
Closed Access | Times Cited: 6
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 15
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy
Yongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Gastroenterology (2024) Vol. 167, Iss. 2, pp. 281-297
Closed Access | Times Cited: 5
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Olamide Tosin Olaoba, Ming Yang, Temitope Isaac Adelusi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1470-1470
Open Access | Times Cited: 5
The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells
Juan Carlos López-Gil, Susana García‐Silva, Laura Ruiz, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1489-1508
Open Access | Times Cited: 5
The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3015-3015
Open Access | Times Cited: 11
Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results
Robert C. Chick, Andrew J. Gunderson, Shafia Rahman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3967-3967
Open Access | Times Cited: 11
Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment
Hideyuki Masui, Kenji Kawada, Yoshiro Itatani, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 1, pp. 63-76
Open Access | Times Cited: 4
The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
Fotini Poyia, Christiana M. Neophytou, Maria Christodoulou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9555-9555
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top